Last update 21 Nov 2024
Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine, Genetically engineered subunit vaccine |
Synonyms Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1998), |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)The Safety and Immunogenicity of 10μg/0.5ml Recombinant Hepatitis B Vaccines(Saccharomyces Cerevisiae) in the Healthy Neonates
新生儿接种10μg/0.5ml规格重组乙型肝炎疫苗（酿酒酵母）的安全性和有效性研究
[Translation] Safety and efficacy of 10 μg/0.5 ml recombinant hepatitis B vaccine (Saccharomyces cerevisiae) in neonates
对16岁及16岁以上健康人群进行的20μg重组乙型肝炎疫苗(酿酒酵母)单中心Ⅳ期临床试验
[Translation] A single-center phase IV clinical trial of 20 μg recombinant hepatitis B vaccine (Saccharomyces cerevisiae) in healthy people aged 16 years and above
100 Clinical Results associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
Login to view more data
100 Deals associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.) | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hepatitis B | CN | 01 Jan 1998 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B | Discovery | - | 01 Nov 2006 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2/3 | 1,091 | (60mcg/1.0ml Recombinant Hepatitis B Vaccine) | arrwvlsagz(cwlkysscvl) = ehfqyjqxfz hfqnsbyoja (brrmncffnq, rgkmqbqgjr - cmslnkiemc) View more | - | 23 Apr 2012 | ||
(30mcg/1.0ml Recombinant Hepatitis B Vaccine) | arrwvlsagz(cwlkysscvl) = xdwmyaaxcp hfqnsbyoja (brrmncffnq, jthjuiprhw - ajogbazapk) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free